Achieve Life Sciences (ACHV) Treasury Shares (2012 - 2015)

Achieve Life Sciences (ACHV) has 15 years of Treasury Shares data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Treasury Shares fell 60.66% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 60.66% YoY) and the FY2025 annual result came in at $1.1 million, down 15.53% from the prior year.
• Treasury Shares was little changed at $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2025 to a low of $252875.0 in Q2 2022.
• A 5-year average of $1.0 million and a median of $1.1 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 374.88% — and 2026, when it plunged 60.66%.
• Tracing ACHV's Treasury Shares over 5 years: stood at $252875.0 in 2022, then soared by 100.84% to $507875.0 in 2023, then jumped by 152.77% to $1.3 million in 2024, then retreated by 15.53% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
• The last three Treasury Shares figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.